Clinical Research Directory
Browse clinical research sites, groups, and studies.
Market Research of a Slow Release Protein Substitute for the Dietary Management of PKU
Sponsor: metaX Institut fuer Diatetik GmbH
Summary
XPhePiccosMR is a prospective, single-arm, open label, observational study that aims to evaluate the acceptability and tolerability of XPhe Piccos, a slow-release, phenylalanine-free protein substitute in the form of tiny tablets, for use in the dietary management of phenylketonuria (PKU) in children aged three years and older.
Official title: XPhe Piccos - Acceptability and Tolerance Market Research
Key Details
Gender
All
Age Range
3 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-10-15
Completion Date
2027-08-01
Last Updated
2026-10-15
Healthy Volunteers
No
Conditions
Interventions
Slow release, phenylalanine-free protein substitute tablets
The slow release, phenylalanine-free protein substitute in tablet form (XPhe Piccos) is a food for special medical purposes (FSMP) for use in the dietary management of Phenylketonuria or Hyperphenylalaninemia. The product is suitable from 3 years of age and over. XPhe Piccos are a highly concentrated phenylalanine-free protein supplement in the form of very small tablets/pellets enriched with vitamins, minerals and trace elements. XPhe Piccos are characterized by a prolonged release of the amino acids.
Locations (1)
Birmingham Children´s Hospital
Birmingham, England, United Kingdom